Please download the dossier by clicking on the dossier button x
×

Heteroaromatic compounds and their use as dopamine D1 ligands

  • US 10,093,655 B2
  • Filed: 10/10/2017
  • Issued: 10/09/2018
  • Est. Priority Date: 06/27/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating a D1-mediated (or D1-associated) disease or disorder in a mammal, which method comprises administering to the mammal a therapeutically effective amount of a compound of Formula I:

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×